Singapore markets closed

ABT Jan 2025 155.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.9200-0.4800 (-14.12%)
At close: 10:40AM EST
Full screen
Previous close3.4000
Open3.1000
Bid2.7600
Ask3.3000
Strike155.00
Expiry date2025-01-17
Day's range2.9200 - 3.1500
Contract rangeN/A
Volume12
Open interest176
  • Motley Fool

    Is Abbott Laboratories a Good Dividend Stock to Buy Now?

    It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-paying stock, in particular, is getting a lot of positive attention. Abbott Laboratories (NYSE: ABT) reported fourth-quarter earnings on Thursday, Jan. 26. Since then, Sanford C. Bernstein, Raymond James, Stifel Nicolaus, and Barclays have all raised their price targets on the healthcare conglomerate.

  • Zacks

    Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say

    While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

  • Motley Fool

    Abbott's Sales and Earnings Are Sinking: Should Investors Worry?

    Abbott (NYSE: ABT) reported its full-year and fourth-quarter results for 2022 on Wednesday. Abbott's bad news definitely jumped out. While Abbott's sales fell 12% on a reported basis, the year-over-year decline was only 6.1% excluding the impact of foreign exchange.